Although neuroimaging research has made substantial progress in identifying the neural substrate of anxiety disorders,
1,2 its value for clinical translational research lags behind expectations. One reason is that most studies are based on conventional group analyses. In contrast, a useful biomarker has to provide sufficient sensitivity and specificity to predict a given patient’s status on the individual level.
3,4 Machine-learning algorithms, such as Support Vector Machines or gaussian process classifiers (GPC), have shown predictive potential for single-subject diagnostic purposes.
5-8